文献速递临床生化质量管理与危急值

Abbott Alinity c 分析系统六种酶测量计量溯源性的验证

Traceability validation of six enzyme measurements on the Abbott Alinity c analytical system.
PubMed 文献 · Clin Chem Lab Med · 2020-01-01

该研究采用IFCC参考测量程序为ALT、ALP、AST、CK、γGT和LDH各赋值三个样本池,在Alinity c系统上测量以评估偏倚和测量不确定度,并用生物学变异导出的分析性能规范作为目标;结果显示六种酶的溯源实施正确,测量不确定度达到理想或最佳水平,且意大利米兰与波兰比得哥什两台Alinity系统间比对一致。

要点

  • 六种酶在Alinity c上的测量结果可正确溯源至IFCC参考测量程序。
  • ALT、CK、γGT的测量不确定度达到最佳APS,ALP、AST、LDH达到理想APS。
  • 两台不同地点的Alinity系统间酶测量结果一致性良好。

核心结论

  • Alinity c分析系统上ALT、ALP、AST、CK、γGT和LDH的测量已正确标准化至IFCC参考测量系统,且不同平台间系统对齐一致。

研究设计与样本

  • 使用IFCC参考测量程序为每种酶的三个样本池赋值并确定不确定度,随后在Abbott Alinity c系统上测量,进行偏倚估计和回归研究,并以生物学变异导出的分析性能规范为目估算测量不确定度。
  • 通过意大利米兰和波兰比得哥什两台Alinity系统间的比对研究验证结果的可转移性。

主要发现

  • 所有评估酶的溯源实施正确,测量不确定度满足理想APS(ALP、AST、LDH)或最佳APS(ALT、CK、γGT)。
  • 米兰与比得哥什两台Alinity系统间所有酶测量结果对齐最佳。

关键数值与推荐

  • 分析性能规范目标基于测量物的生物学变异导出。
  • ALP、AST、LDH的测量不确定度满足理想APS;ALT、CK、γGT满足最佳APS。

临床怎么用

  • 检验科可参考该验证思路独立确认商业测量系统的计量溯源性及性能是否满足临床用途。
  • 对于采用Alinity c系统开展上述六种酶检测的实验室,结果可追溯至IFCC参考方法且平台间一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Laboratory professionals should independently verify the correct implementation of metrological traceability of commercial measuring systems and determine if their performance is fit for purpose. We evaluated the trueness, uncertainty of measurements, and transferability of six clinically important enzyme measurements (alanine aminotransferase [ALT], alkaline phosphatase [ALP], aspartate aminotransferase [AST], creatine kinase [CK], γ-glutamyltransferase [γGT], and lactate dehydrogenase [LDH]) performed on the Abbott Alinity c analytical system. Methods Target values and associated uncertainties were assigned to three pools for each enzyme by using the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) reference measurement procedures (RMPs) and the pools were then measured on the Alinity system. Bias estimation and regression studies were performed, and the uncertainty associated with Alinity measurements was also estimated, using analytical performance specifications (APS) derived from biological variability of measurands as goals. Finally, to validate the transferability of the obtained results, a comparison study between two Alinity systems located in Milan, Italy, and Bydgoszcz, Poland, was carried out. Results Correct implementation of traceability to the IFCC RMPs and acceptable measurement uncertainty fulfilling desirable (ALP, AST, LDH) or optimal APS (ALT, CK, γGT) was verified for all evaluated enzymes. An optimal alignment between the two Alinity systems located in Milan and Bydgoszcz was also found for all enzyme measurements. Conclusions We confirmed that measurements of ALT, ALP, AST, CK, γGT, and LDH performed on the Alinity c analytical system are correctly standardized to the IFCC reference measurement systems and the system alignment is consistent between different platforms.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Aloisio E, Frusciante E, Pasqualetti S, et al. Traceability validation of six enzyme measurements on the Abbott Alinity c analytical system. Clin Chem Lab Med. 2020. PMID: 32126012. doi:10.1515/cclm-2020-0015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。